Plasma Cell Leukaemia clinical trials

Explore recruiting plasma cell leukaemia clinical trials.

Recruiting plasma cell leukaemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Plasma Cell Leukaemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase II, multicenter, open-label, prospective, non-randomized study to evaluate the safety and efficacy of ARI0002h, a CAR-T cell against BCMA, for the initial treatment of patients with primary plasma cell leukaemia

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Plasma Cell Leukaemia trials by city

Plasma Cell Leukaemia in Toronto Plasma Cell Leukaemia in Vancouver Plasma Cell Leukaemia in Montreal Plasma Cell Leukaemia in Calgary Plasma Cell Leukaemia in Edmonton Plasma Cell Leukaemia in Ottawa Plasma Cell Leukaemia in Winnipeg Plasma Cell Leukaemia in Quebec City Plasma Cell Leukaemia in Hamilton Plasma Cell Leukaemia in Kitchener Plasma Cell Leukaemia in London Plasma Cell Leukaemia in Halifax Plasma Cell Leukaemia in New York Plasma Cell Leukaemia in Los Angeles Plasma Cell Leukaemia in Chicago Plasma Cell Leukaemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease